Strong H1 2026 results with 15.3% revenue growth and 18.3% higher adjusted EBITDA, driven by robust demand in defense and surveillance. Capacity expansion and recent acquisitions support upgraded full-year guidance and mid-term growth outlook.Original document: Exosens SA [EXENS] Slides Release — J…
Strong H1 2026 results with 15.3% revenue growth and 18.3% higher adjusted EBITDA, driven by robust demand in defense and surveillance. Capacity expansion and recent acquisitions support upgraded full-year guidance and mid-term growth outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.